Steve Krognes, M.B.A.

Steve Krognes, M.B.A.

DirectoratPliant Therapeutics· In proxies 2023–2025

Steve Krognes, M.B.A. sits on 20 public boards.

Boards1

  • Denali TherapeuticsDirector · 3 yr on the boardIndependentAudit—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Pliant TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role -95%
  2. Denali TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Guardant HealthPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  4. Alveus TherapeuticsPublic company · Less than 1 yr
    • Director2026 – Present · Less than 1 yrNo stock prices for these years
  5. ClavystBioPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  6. SEPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  7. Argenx SEPublic company
    • Director? – PresentNo stock prices for these years
  8. Pliant TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  9. Addex Therapeutics Ltd.Public company
    • Director? – PresentNo stock prices for these years
  10. Facet Biotech CorporationPublic company
    • Director? – PresentNo stock prices for these years
  11. Nektar Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  12. RLS Global ABPublic company
    • Director? – PresentNo stock prices for these years
  13. Rezolute, Inc.Public company
    • Director? – PresentNo stock prices for these years
  14. S.p.APublic company
    • Director? – PresentNo stock prices for these years
  15. Corvus Pharmaceuticals, Inc.Public company · 5 yr
    • Director2016 – 2021 · 5 yrNo stock prices for these years
  16. Corvus Pharmaceuticals, Inc.Public company · 5 yr
    • Director2016 – 2021 · 5 yrNo stock prices for these years
  17. AntriaBio, Inc.Public company · 6 yr
    • Director2013 – 2019 · 6 yrNo stock prices for these years
  18. SciencesPublic company · 4 yr
    • Director2014 – 2018 · 4 yrNo stock prices for these years
  19. CytomX Therapeutics, Inc.Public company · 6 yr
    • Director2012 – 2018 · 6 yrNo stock prices for these years
  20. Geron CorporationPublic company · 7 yr
    • Director2011 – 2018 · 7 yrNo stock prices for these years
  21. Epizyme, Inc.Public company · 3 yr
    • Director2009 – 2012 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?